Format

Send to

Choose Destination
Pediatr Infect Dis J. 2012 Feb;31(2):197-9. doi: 10.1097/INF.0b013e31823980c3.

Pharmacokinetics of moxifloxacin in an infant with Mycoplasma hominis meningitis.

Author information

1
Department of Pediatrics, Duke University Medical Center, Durham, NC 27599, USA.

Abstract

Treatment of Mycoplasma hominis meningitis in infants is limited by a lack of consensus regarding therapy and limited pharmacokinetic data for agents to which M. hominis is susceptible. We report the successful treatment of a premature infant suffering from M. hominis meningitis with doxycycline and moxifloxacin and provide a pharmacokinetic profile of moxifloxacin.

PMID:
22016080
PMCID:
PMC3358780
DOI:
10.1097/INF.0b013e31823980c3
[Indexed for MEDLINE]
Free PMC Article

Publication types, MeSH terms, Substances, Grant support

Publication types

MeSH terms

Substances

Grant support

Supplemental Content

Full text links

Icon for Wolters Kluwer Icon for PubMed Central
Loading ...
Support Center